Works matching Prion disease treatment
Results: 128
Treatment of Prion Disease with Heterologous Prion Proteins.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131993
- By:
- Publication type:
- Article
Pharmacokinetics of quinacrine in the treatment of prion disease.
- Published in:
- BMC Infectious Diseases, 2004, v. 4, n. 1, p. 53, doi. 10.1186/1471-2334-4-53
- By:
- Publication type:
- Article
Copaxone interferes with the PrP<sup>Sc</sup>–GAG interaction.
- Published in:
- European Journal of Neurology, 2007, v. 14, n. 8, p. 877, doi. 10.1111/j.1468-1331.2007.01803.x
- By:
- Publication type:
- Article
Therapeutic effect of peripheral administration of an anti-prion protein antibody on mice infected with prions.
- Published in:
- Microbiology & Immunology, 2013, v. 57, n. 4, p. 288, doi. 10.1111/1348-0421.12037
- By:
- Publication type:
- Article
Effective Gene Therapy in a Mouse Model of Prion.
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002773
- By:
- Publication type:
- Article
Miscellaneous.
- Published in:
- Current Medical Literature: Neurology, 2008, v. 24, n. 3, p. 91
- Publication type:
- Article
Continuous intraventricular infusion of pentosan polysulfate: Clinical trial against prion diseases.
- Published in:
- Neuropathology, 2009, v. 29, n. 5, p. 632, doi. 10.1111/j.1440-1789.2009.01058.x
- By:
- Publication type:
- Article
Attempt to isolate subfraction of mouse mesenchymal stem cells and production of mesenchymal stem cells expressing anti-PrP antibodies.
- Published in:
- Japanese Journal of Veterinary Research, 2013, v. 61, n. 1/2, p. 74
- By:
- Publication type:
- Article
The N-Terminal, Polybasic Region Is Critical for Prion Protein Neuroprotective Activity.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025675
- By:
- Publication type:
- Article
Targeting of poly(l-lysine) to organs that propagate prions.
- Published in:
- Journal of Bioactive & Compatible Polymers, 2014, v. 29, n. 5, p. 432, doi. 10.1177/0883911514542898
- By:
- Publication type:
- Article
Molecular Nanobiotechnological approaches for the detection and therapy of prion related diseases.
- Published in:
- Nano Biomedicine & Engineering, 2012, v. 4, n. 2, p. 50, doi. 10.5101/nbe.v4i2.p50-57
- By:
- Publication type:
- Article
Ultraviolet-ozone treatment reduces levels of disease-associated prion protein and prion infectivity.
- Published in:
- BMC Research Notes, 2009, v. 2, p. 121, doi. 10.1186/1756-0500-2-121
- Publication type:
- Article
Fatal familial insomnia with abnormal signals on routine MRI: a case report and literature review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prion diseases and dental treatment: principles and practice of patients with/suspected or at-risk of CJD: Case reports.
- Published in:
- British Dental Journal, 2003, v. 195, n. 6, p. 319, doi. 10.1038/sj.bdj.4810542
- By:
- Publication type:
- Article
In Vivo Longitudinal H MRS Study of Transgenic Mouse Models of Prion Disease in the Hippocampus and Cerebellum at 14.1 T.
- Published in:
- Neurochemical Research, 2015, v. 40, n. 12, p. 2639, doi. 10.1007/s11064-015-1643-9
- By:
- Publication type:
- Article
The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.
- Published in:
- Nature, 2013, v. 501, n. 7465, p. 102, doi. 10.1038/nature12402
- By:
- Publication type:
- Article
Dendrimers as therapeutic agents: a systematic review.
- Published in:
- Journal of Pharmacy & Pharmacology, 2009, v. 61, n. 8, p. 989, doi. 10.1211/jpp.61.08.0002
- By:
- Publication type:
- Article
Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Potential approaches for heterologous prion protein treatment of prion diseases.
- Published in:
- Prion, 2016, v. 10, n. 1, p. 18, doi. 10.1080/19336896.2015.1123372
- By:
- Publication type:
- Article
P.185: Quinacrine and its bioavailability in treatment of prion disease.
- Published in:
- Prion, 2014, v. 8, p. 112
- By:
- Publication type:
- Article
Nanomedicine for prion disease treatment.
- Published in:
- Prion, 2013, v. 7, n. 3, p. 198, doi. 10.4161/pri.24431
- By:
- Publication type:
- Article
Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
- Published in:
- Vox Sanguinis, 2011, v. 101, n. 1, p. 28, doi. 10.1111/j.1423-0410.2010.01456.x
- By:
- Publication type:
- Article
Is There Still Hope After Prions Have Spread Within the Brain?
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 7, p. 978, doi. 10.1093/infdis/jir487
- By:
- Publication type:
- Article
Pharmacological Agents Targeting the Cellular Prion Protein.
- Published in:
- Pathogens, 2018, v. 7, n. 1, p. 27, doi. 10.3390/pathogens7010027
- By:
- Publication type:
- Article
The anti-fibrillogenic activity of tetracyclines on PrP 106–126: a 3D-QSAR study.
- Published in:
- Journal of Molecular Modeling, 2008, v. 14, n. 10, p. 987, doi. 10.1007/s00894-008-0348-2
- By:
- Publication type:
- Article
Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges.
- Published in:
- 2018
- By:
- Publication type:
- journal article
P2-380: Identification and characterization of human autoantibodies that may be used for the treatment of prion diseases
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O4-04-02: Therapeutic effects of gene therapy in the late treatment of prion diseases
- Published in:
- 2008
- By:
- Publication type:
- Abstract
A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 12, p. 1, doi. 10.1371/journal.ppat.1006045
- By:
- Publication type:
- Article
From Scientific Curiosity to Public Enemy Number One in Six Short Months.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 4, p. 1, doi. 10.1371/journal.ppat.1005371
- By:
- Publication type:
- Article
“Big data” gets personal.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 322, p. 1, doi. 10.1126/scitranslmed.aad9460
- By:
- Publication type:
- Article
Protein Folding Activity of the Ribosome (PFAR) — A Target for Antiprion Compounds.
- Published in:
- Viruses (1999-4915), 2014, v. 6, n. 10, p. 3907, doi. 10.3390/v6103907
- By:
- Publication type:
- Article
Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 89, n. 6, p. 932, doi. 10.1111/cbdd.12918
- By:
- Publication type:
- Article
Remarkable reductions of PAKs in the brain tissues of scrapie-infected rodent possibly linked closely with neuron loss.
- Published in:
- Medical Microbiology & Immunology, 2014, v. 203, n. 5, p. 291, doi. 10.1007/s00430-014-0342-5
- By:
- Publication type:
- Article
Alkylating Antitumor Drug Mechlorethamine Conceals A Structured PrP Domain and Inhibits in Vitro Prion Amplification.
- Published in:
- Journal of Toxicology & Environmental Health: Part A, 2011, v. 74, n. 22-24, p. 1493, doi. 10.1080/15287394.2011.618978
- By:
- Publication type:
- Article
Selective propagation of mouse-passaged scrapie prions with long incubation period from a mixed prion population using GT1-7 cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179317
- By:
- Publication type:
- Article
Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177876
- By:
- Publication type:
- Article
2-Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease.
- Published in:
- ChemMedChem, 2013, v. 8, n. 5, p. 847, doi. 10.1002/cmdc.201300007
- By:
- Publication type:
- Article
Combinatory FK506 and Minocycline Treatment Alleviates Prion-Induced Neurodegenerative Events via Caspase-Mediated MAPK-NRF2 Pathway.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1144, doi. 10.3390/ijms20051144
- By:
- Publication type:
- Article
Prospects for the Pharmacological Treatment of Human Prion Diseases.
- Published in:
- CNS Drugs, 1998, v. 10, n. 2, p. 83, doi. 10.2165/00023210-199810020-00001
- By:
- Publication type:
- Article
NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.
- Published in:
- Cellular & Molecular Life Sciences, 2012, v. 69, n. 24, p. 4215, doi. 10.1007/s00018-012-1140-0
- By:
- Publication type:
- Article
Europe kicks off prion research network.
- Published in:
- Nature Medicine, 2004, v. 10, n. 7, p. 655, doi. 10.1038/nm0704-655b
- By:
- Publication type:
- Article
Immunization treatment approaches in Alzheimer’s and prion diseases.
- Published in:
- Current Neurology & Neuroscience Reports, 2002, v. 2, n. 5, p. 400, doi. 10.1007/s11910-002-0065-7
- By:
- Publication type:
- Article
RNAi: a novel strategy for the treatment of prion diseases.
- Published in:
- Journal of Clinical Investigation, 2006, v. 116, n. 12, p. 3101, doi. 10.1172/JCI30663
- By:
- Publication type:
- Article
Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01868-x
- By:
- Publication type:
- Article
Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0383-7
- By:
- Publication type:
- Article
A Discrete-Time Branching Process Model of Yeast Prion Curing Curves*.
- Published in:
- Mathematical Population Studies, 2013, v. 20, n. 1, p. 1, doi. 10.1080/08898480.2013.748566
- By:
- Publication type:
- Article
Cellulose ether treatment in vivo generates chronic wasting disease prions with reduced protease resistance and delayed disease progression.
- Published in:
- Journal of Neurochemistry, 2020, v. 152, n. 6, p. 727, doi. 10.1111/jnc.14877
- By:
- Publication type:
- Article
Proceedings of 2nd Annual Charles River World Congress: Lessons Learned from Rare Disease and Personalized Medicine Approaches.
- Published in:
- 2018
- Publication type:
- Abstract
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article